CFD Modelling of Coupled Multiphysics-Multiscale Engineering Cases

Many of the engineering problems have multiphysics and multiscale nature. Non-isothermal flows, stirred reactors, turbulent mixing and membrane filtration, are prevalent cases in which the coupling of several physics phenomena is required for the adequate prediction of overall behaviors. Also, a multiscale analysis, where the same phenomenon is analyzed at different scales, can lead to better understanding of the phenomena, which can be used in optimization and to provide adequate scale-up methodologies. Studies incorporating both multiscale and multiphysics analysis are rarely addressed in literature; in fact, these kinds of problems will be the research challenge in the next years. Computer fluid dynamics (CFD) techniques have shown to be promising to deal with these kinds of systems. In this chapter, these are used to implement a multiscale analysis of the hydrodesulphurization (HDS) process for light gas-oil (LGO). The aforementioned is carried out by the analysis of mass an energy transport at: (1) microporous (MP) scale, (2) pseudo-homogeneous catalyst (PHC) scale, and by analysis of (3) momentum and mass transport at reactor scale (RS). In addition, a particular discussion is made regarding the proper establishment of the model, its validation, the use of different boundary conditions, its justification; and the dependence of solutions of parameters and initial and boundary conditions

Clinical trial evaluating the effectiveness of biocompound IMMUNEPOTENT CRP in the third-molar extraction

ABSTRACT A controlled, parallel, randomized and comparative trial was carried out to evaluate the antiinflammatory efficacy of IMMUNEPOTENT CRP versus ibuprofen in patients after third-molar surgery over seven days. The anti-inflammatory efficacy of IMMUNEPOTENT CRP was evaluated using the method of Amin and Laskin, and the analysis of cytokine production (IL-2, IL-4, IL-6, IL-10, TNF-a, INF-g) in saliva was done by flow cytometry. The swelling process after surgery was significant (p < 0.05) and the treatments with IMMUNEPOTENT CRP or ibuprofen controlled this process properly; no difference between the groups was found (p < 0.05). Both treatments were shown to modulate the cytokine production. These results demonstrate the anti-inflammatory activity of the natural compound IMMUNEPOTENT CRP and suggest it could be used in clinical dental practice

UFR2709, a nicotinic acetylcholine receptor antagonist, decreases ethanol intake in alcohol-preferring rats

Brain nicotinic acetylcholine receptors (nAChRs), a heterogeneous family of pentameric acetylcholine-gated cation channels, have been suggested as molecular targets for the treatment of alcohol abuse and dependence. Here, we examined the effect of the competitive nAChR antagonist UFR2709 on the alcohol consumption of high-alcohol-drinking UChB rats. UChB rats were given free access to ethanol for 24-h periods in a two-bottle free-choice paradigm and their ethanol and water intake were measured. The animals were i.p injected daily for 17 days with a 10, 5, 2.5 or 1 mg/kg dose of UFR2709. Potential confounding motor effects of UFR2709 were assessed by examining the locomotor activity of animals administered the highest dose of UR2709 tested (10 mg/kg i.p.). UFR2709 reduced ethanol consumption and ethanol preference and increased water consumption in a dose-dependent manner. The most effective dose of UFR2709 was 2.5 mg/kg, which induced a 56% reduction in alcohol consumption. Administration of UFR2709 did not affect the weight or locomotor activity of the rats, suggesting that its effects on alcohol consumption and preference were mediated by specific nAChRs